Does Stepwise Voltage Ramping Protect the Kidney from Injury During Extracorporeal Shockwave Lithotripsy? Results of a Prospective Randomized Trial
Eur Urol · 2016 · Vol. 69 · Issue 2 · 267-273
Academy Summary
Does Stepwise Voltage Ramping Protect the Kidney from Injury During Extracorporeal Shockwave Lithotripsy? Results of a Prospective Randomized Trial examined a clinically important component of shock wave lithotripsy, with particular relevance to SWL Treatment Optimisation.
The investigators used a Prospective Randomized Controlled Trial in adults undergoing swl for kidney stones. This design strengthens comparison between the treatment strategies studied, although the conclusions still remain tied to the lithotripter, protocol and eligibility criteria used.
A large randomized trial reported fewer renal hematomas with stepwise voltage ramping than fixed-power treatment while maintaining treatment efficacy.
Energy ramping is not simply a comfort manoeuvre. It is a method of designing the biological and mechanical dose of SWL.
This study contributes to the evidence that the sequence in which shock-wave energy is delivered can influence both stone comminution and renal tissue response. The objective is to reach effective fragmentation energy while limiting unnecessary renal vascular and parenchymal stress.
Published in 2016, the study should still be interpreted according to its specific lithotripter, patient selection and outcome definitions rather than assumed to represent every modern SWL system.
For the Lithotripsy Academy database, the paper is most useful when interpreted as part of the complete treatment pathway rather than as an isolated numerical rule. Patient selection determines the opportunity for success, while targeting, coupling, shock-wave rate, energy strategy and operator technique determine how effectively that opportunity is converted into fragmentation and clearance.
Comments & Discussion0 comments
Discuss the publication's evidence, limitations and practical relevance. Please do not include identifiable patient information or individual medical advice.
No comments yet. Start the discussion.
Please log in to join the discussion.
